Published March 2, 2020
BUFFALO, N.Y. – The University at Buffalo School of Pharmacy and Pharmaceutical Sciences and the College of Staten Island (CSI) have formed three new collaborative agreements that provide CSI students opportunities to earn a doctor of pharmacy degree.
A memorandum of agreement was formally signed on in Feb. 2020 by College of Staten Island Dean Dr. Michael Cavagnero and UB School of Pharmacy and Pharmaceutical Sciences Dean James M. O’ Donnell, PhD.
Cavagnero stated, “We are very proud to be partnering with University at Buffalo to offer a PharmD degree. This incredible opportunity represents not only a significant tuition savings to our students via a CUNY/SUNY partnership, but also offers a top-notch accelerated program and rich academic experience with renowned professors and one-on-one advisement, which will allow our students to earn a Doctorate in Pharmacy in as little as six years.”
Under the 2+4 and 4+4 agreements, students will complete their undergraduate studies at the College of Staten Island and then apply to UB’s pharmacy program. These recruitment partnerships establish pathways for students of all required prerequisite courses.
Under the 3+4 agreement, students will complete three years of undergraduate study in the College of Staten Island’s biology or chemistry program and then apply to UB’s pharmacy program. Once accepted, students will have their first-year pharmacy courses applied toward completion of their bachelor’s degree at the College of Staten Island. Rather than taking four years to complete a bachelor’s degree and another four years to complete the doctor of pharmacy degree, students will complete both programs in seven years. The pharmacy program will guarantee spaces each year for qualified College of Staten Island students.
Discussing the partnership, O’Donnell said, “The University at Buffalo School of Pharmacy and Pharmaceutical Sciences values our strong collaboration with the College of Staten Island, and our agreements will further solidify this partnership. We look forward to having their best and brightest students as members of our PharmD program.”